Effects of interleukin-10 on titanium particle-induced macrophage transcription factor activation and cytokine expression in vitro

Journal of Biomedical Materials Research - Part A

Volumn 69, Issue 1, 2004, Pages 40-46

  Wong, Neal ^a   Trindade, Michael C D ^a   Patel, Raj ^a   Yaszay, Burt ^a   Goodman, Stuart B ^a   Smith, R Lane ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Macrophages; Titanium particles; Total joint arthroplasty; Transcription factors

Indexed keywords

BIOASSAY; ELECTROPHORESIS; PROTEINS; TITANIUM;

NUCLEAR PROTEINS;

BIOMATERIALS;

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; NUCLEAR PROTEIN; TITANIUM; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE ACTIVATION; PROTEIN LOCALIZATION;

EID: 1642335719     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.20097     Document Type: Article

References (44)

1. Amstutz HC, Campbell P, Kossovsky N, Clarke IC. Mechanism and clinical significance of wear debris-induced osteolysis. Clin Orthop 1992;276:7-18.
2. Schmalzried TP, Jasty M, Harris WH. Periprosthetic bone loss in total hip arthroplasty: the role of polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg 1992;74A:849-863.
3. Peters PC Jr, Engh GA, Dwyer KA, Vinh TN. Osteolysis after total knee arthroplasty without cement. J Bone Joint Surg 1992;74A:864-876.
4. Goodman SB, Huie P, Song Y, Lee K, Doshi A, Rushdieh B, Woolson S, Maloney W, Schurman D, Sibley R. Loosening and osteolysis of cemented joint arthroplasties. Clin Orthop 1997;337:149-163.
5. Goodman SB, Knoblich G, O'Connor M, Song Y, Huie P, Sibley R. Heterogeneity in cellular and cytokine profiles from multiple samples of tissue surrounding revised hip prostheses. J Biomed Mater Res 1996;31:421-428.
6. Williams RP, McQueen DA. A histopathologic study of late aseptic loosening of cemented total hip prostheses. Clin Orthop 1992;275:174-179.
7. Chiba J, Rubash HE, Kim KJ, Iwaki Y. The characterization of cytokines in the interface tissue obtained from failed cementless total hip arthroplasty with and without femoral osteolysis. Clin Orthop 1994;300:304-312.
8. Murray DW, Rushton N. Mediators of bone resorption around implants. Clin Orthop 1992;281:295-304.
9. Ohlin A, Johnell O, Lerner UH. The pathogenesis of loosening of total hip arthroplasties. The production of factors by periprosthetic tissues that stimulate in vitro bone resorption. Clin Orthop 1990;253:287-296.
10. Maloney WJ, Smith RL. Periprosthetic osteolysis in total hip arthroplasty: the role of particulate wear debris. J Bone Joint Surg 1995;77A:1448-1461.
11. Brennan FM, Maini RN, Feldman M. Cytokine expression in chronic inflammatory disease. Br Med Bull 1995;51:368-384.
12. West MA, Bennet T, Clair L. Reprogrammed macrophage tumor necrosis factor and interleukin-1 release with inflammatory pretreatment: differential regulation by endotoxin and zymosan. J Trauma 1995;39:404-410.
13. Herbein G, Doyle AG, Montaner LJ, Gordon S. Lipopolysaccharide (LPS) down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor (TNF) and IL-1beta. Clin Exp Immunol 1995;102:430-437.
14. Papavassiliou AG. Transcription factors. N Engl J Med 1995;332:45-47.
15. Zheng ZM, Specter S. Dynamic production of tumour necrosis factor-alpha (TNF-alpha) messenger RNA, intracellular and extracellular TNF-alpha by murine macrophages and possible association with protein tyrosine phosphorylation of STAT1 alpha and ERK2 as an early signal. Immunology 1996;87:544-550.
16. Dendorfer U. Molecular biology of cytokines. Artif Organs 1996;20:437-444.
17. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992;10:411-452.
18. Collart MA, Baeuerle P, Vassalli P. Regulation of tumor necrosis factor-α transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol Cell Biol 1990;10:1498-1506.
19. Shimizu H, Mitomo K, Watanabe T, Okamoto S, Yamamoto KI. Involvement of a NF-κB like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol Cell Biol 1990;10:561-568.
20. Matsusaka S, Fujikawa K, Nishio Y. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 1993;90:10193-10197.
21. Akira S, Isshiki H, Sugita T. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 1990;9:1897-1906.
22. Nakashima Y, Sun DH, Trindade MCD, Maloney WJ, Goodman SB, Schurman DJ, Smith RL. Signaling pathways for tumor necrosis factor-alpha and interleukin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro. J Bone Joint Surg 1999;81A:603-615.
23. Schwarz EM, Lu AP, Goater JJ, Benz EB, Kollias G, Rosier RN, Puzas JE, O'Keefe RJ. Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. J Orthop Res 2000;18:472-480.
24. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 1994;153:811-816.
25. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. Interleukin (IL)-10 inhibits nuclear factor κB (NF-κB) activation in human monocytes. J Biol Chem 1996;270:9558-9563.
26. Trindade MC, Lind M, Nakashima Y, Sun D, Goodman SB, Schurman DJ, Smith RL. Interleukin-10 inhibits polymethylmethacrylate particle induced interleukin-6 and tumor necrosis factor-alpha release by human monocyte/macrophages in vitro. Biomaterials 2001;22:2067-2073.
27. Pollice PF, Hsu J, Hicks DG, Bukata S, Rosier RN, Reynolds PR, Puzas JE, O'Keefe RJ. Interleukin-10 inhibits cytokine synthesis in monocytes stimulated by titanium particles: evidence of an anti-inflammatory regulatory pathway. J Orthop Res 1998;16:697-704.
28. Ragab AA, Van De Motter R, Lavish SA, Goldberg VM, Ninomiya JT, Carlin CR, Greenfield EM. Measurement and removal of adherent endotoxin from titanium particles and implant surfaces. J Orthop Res 1999;17:803-808.
29. Hitchins VM, Merritt K. Decontaminating particles exposed to bacterial endotoxin (LPS). J Biomed Mater Res 1999;46:434-437.
30. Nakashima Y, Sun DH, Maloney WJ, Goodman SB, Schurman DJ, Smith RL. Induction of matrix metalloproteinase expression in human macrophages by orthopaedic particulate debris in vitro. J Bone Joint Surg Br 1998;80:694-700.
31. Lind M, Trindade MC, Schurman DJ, Goodman SB, Smith RL. Monocyte migration inhibitory factor synthesis and gene expression in particle-activated macrophages. Cytokine 2000;12:909-913.
32. Flanagan WM, Corthesy B, Bram RJ, Crabtree GR. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 1991;352:803-807.
33. Blaine TA, Pollice PF, Rosier RN, Reynolds PR, Puzas JE, O'Keefe RJ. Modulation of the production of cytokines in titanium-stimulated human peripheral blood monocytes by pharmacological agents. J Bone Joint Surg 1997;79A:1519-1528.
34. Lee SH, Brennan FR, Jacobs JJ, Urban RM, Ragasa DR, Glant TT. Human monocyte/macrophage response to cobalt-chromium corrosion products and titanium particles in patients with total joint replacements. J Orthop Res 1997;15:40-49.
35. Kadoya Y, Revell PA, Al-Saffar N, Kobayashi A, Scott G, Freeman MAR. Bone formation and bone resorption in failed total joint arthroplasties: histomorphometric analysis with histochemical and immunohistochemical technique. J Orthop Res 1996;14:473-482.
36. Goodman SB, Chin RC, Chiou SS, Schurman DJ, Woolson ST, Masada MP. A clinical-pathologic-biochemical study of the membrane surrounding loosened and nonloosened total hip arthroplasties. Clin Orthop 1989;244:182-187.
37. Maloney WJ, James RE, Smith RL. Human macrophage response to retrieved titanium alloy particles in vitro. Clin Orthop 1996;322:268-278.
38. Liou HC. Regulation of the immune system by NF-kappaB and IkappaB. J Biochem Mol Biol 2002;35:537-546.
39. Hanada T, Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev 2002;13:413-421.
40. Heller RA, Kronke M. Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol 1994;126:5-9.
41. Koj A. Initiation of acute phase response and synthesis of cytokines. Biochim Biophys Acta 1996;1317:84-94.
42. Ritchie CK, Paczkoskie VJ, Horowitz SM. Role of cyclic AMP in particulate-induced cytokine production in macrophages. Trans Orthop Res Soc 1997;22:160.
43. Isshiki H, Akira S, Tanabe O. Constitutive and IL-1 inducible factors interact with the IL-1 responsive element in the IL-6 gene. Mol Cell Biol 1990;10:2757-2764.
44. Akira S, Kishimoto T. NF-IL6 and NF-kappaB in cytokine gene regulation. Adv Immunol 1997;65:1-46.